PROXIMAMENTE

The future of aPL testing: 
– Criteria aPL tests coming to age: are they still useful?
– Novel and non-criteria specificities: are these useful?
– New technologies taking over aPL testing

  • New APS criteria: an update
  • Mechanisms of aPL mediated thrombosis
  • COVID 19, vaccines and aPL 
  • COVID 19, thrombosis and aPL
  • Lupus and APS
  • Cardiovascular risk and aPL
  • Neuropsychiatric APS
  • Imaging in APS
  • Disease activity, damage, risk scores and quality of life in APS 
  • Mechanisms of aPL mediated pregnancy morbidity
  • Fertility and APS
  • Transplantation and APS
  • Thromboprophylaxis and management of thrombosis in APS
  • Obstetric management in APS
  • Catastrophic APS
  • Pediatric APS
  • What have we learned using animal models of APS
  • Novel potential targets for the treatment of APS

TEN TOPICS

  • Advances in diagnosis and treatment
  • Rheumatoid Arthritis
  • Autoinflammatory diseases
  • Ankylosing spondilytis
  • Uveitis and IBD
  • Psoriatic arthritis
  • SLE
  • Scleroderma
  • Treat to target
  • Myositis
  • Vasculitis
  • Interstitial lung disease: advances in diagnosis and treatment

MET GROUP S.A. TODOS LOS DERECHOS RESERVADOS © 2020